News

When a massive tree toppled in the floodplains of Fonte Boa, a region in the Brazilian Amazon, local fishermen noticed ...
Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced ...
Records, court filings and emails reveal how federal review of Enbridge's Great Lakes tunnel project leaves tribal officials ...
Biocon Ltd's arm, Biocon Biologics Ltd, has received European Commission authorisation for its Vevzuo and Evfraxy biosimilars ...
Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand).
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today announced that ...
Glastonbury may have taken over our television screens but closer to home festival fever has arrived in Llangollen. Texas ...
Biocon Biologics was granted marketing authorisation by the European Commission for Vevzuo and Evfraxy biosimilars of Denosumab used in the treatment of different bone diseases.
A groundbreaking study of 7,000-year-old exposed coral reef fossils reveals how human fishing has transformed Caribbean reef ...
Biocon Biologics gets EU approval for Denosumab biosimilars Vevzuo & Evfraxy, expanding access to bone disease treatments across Europe.
To compare fossilized and modern reefs, scientists collected, quantified and measured thousands of skeletal remains, ...
Headlining the latest TK Maxx presents Live at Llangollen Pavilion night, the triple BRIT Award and Ivor Novello Award winner ...